Maintenance dosing maintains stable levels with 50-100mg injections administered 1-2 times per week for ongoing cellular health support
Lipid-based vesicles are used for agent delivery, because they are able to cross the cell plasmatic membrane and have low cytotoxicity, but there are other more effective delivery systems available, such as nanoparticles, e.g
Zeno, Courtney Lee, Cindy Crawford, Raheleh Khorsan, Avi R
Novo Nordisk, for instance, developed the drug liraglutide, which was a daily injection, and long-acting GLP-1 agonists such as semaglutide, a weekly injection
Topilina, N.I
J Physiol 601(6):10611075 Stevenson-Hoare J, Schalkamp AK, Sandor C, Hardy J, Escott-Price V (2023) New cases of dementia are rising in elderly populations in Wales, UK